Amantadine--what next? (Record no. 710387)

MARC details
000 -LEADER
fixed length control field 00801 a2200229 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250511144922.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 197812s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0305-7453
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/jac/4.4.295
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Stuart-Harris, C
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19781202
245 00 - TITLE STATEMENT
Title Amantadine--what next?
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Journal of antimicrobial chemotherapy
Date of publication, distribution, etc. Jul 1978
300 ## - PHYSICAL DESCRIPTION
Extent 295-7 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Amantadine
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Influenza, Human
General subdivision prevention & control
773 0# - HOST ITEM ENTRY
Title The Journal of antimicrobial chemotherapy
Related parts vol. 4
-- no. 4
-- p. 295-7
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/jac/4.4.295">https://doi.org/10.1093/jac/4.4.295</a>
Public note Available from publisher's website

No items available.